We have moved past the time when pills and medications are the only sources of treatment. The increasing demand for digital treatments and supplemental services shows the need for pharma manufacturing companies to be willing to let go of the "traditional" models and embrace new solutions.
In this episode, we are privileged to host Amy West, head of U.S. Digital Transformation & Innovation at Novo Nordisk. Amy discusses Novo Nordisk's vision of identifying the true pain point of end-users and developing solutions to meet the needs of customers beyond pharmacotherapy. She shares how innovations in tech touch pharma and reasons why pharmaceutical companies should move beyond the pill. She emphasizes the importance of taking a patient-centric approach to deliver value and discusses some examples of wraparound services to address challenges. This is a fascinating conversation you don’t want to miss!
Click this link to the show notes, transcript, and resources: outcomesrocket.health
Outcomes Rocket